About 119 results.

APPROVED DRUG LIBRARY

CCD:CCD08293745

Synonyms:APPROVED DRUG LIBRARY;上市药物库

http://www.chemcd.com/prodetailCCD08293745.html

First data backs efficacy of BMS' novel HIV drug

First data backs efficacy of BMS' novel HIV <span class='lighter'>drug</span>
2015-10-30 A Bristol-Myers Squibb (BMS) drug that causes immature HIV particles to be released from cells early, interrupting their lifecycle, has cleared a proof-of-concept study.
http://www.chemcd.com/news/19786.html

Scottish patients get access to Roche's CLL drug on NHS

2014-12-09 From today patients in Scotland with chronic lymphocytic leukaemia (CLL) have gained ‘routine’ access to a new treatment option after cost-regulators approved Roche’s Gazyvaro (obinutuzumab) for National Health Service use in the country.

http://www.chemcd.com/news/8766.html

Gilead hepatitis C drug Sovaldi racks up $3.5 billion in quarter

2014-07-24 Gilead Sciences Inc said on Wednesday that its new hepatitis C drug Sovaldi had sales of $3.5 billion in the second quarter, demonstrating that the furor over its price has not curtailed early use.

http://www.chemcd.com/news/1146.html

European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment

2014-08-05 Alexion Pharmaceuticals (NASDAQ:ALXN) today announced that the European Commission has granted orphan drug designation (ODD) to Soliris? (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

http://www.chemcd.com/news/1814.html

ABBVIE RECEIVES EMA AND FDA ORPHAN DRUG DESIGNATION FOR INVESTIGATIONAL COMPOUND ABT-414

2014-08-06 AbbVie today announced the EMA and FDA have granted orphan drug designation to AbbVie's investigational compound ABT-414, an anti-epidermal growth factor receptor antibody drug conjugate, which is being evaluated for safety and efficacy in patients with glioblastoma multiforme.

http://www.chemcd.com/news/1918.html

Alnylam Receives Orphan Drug Designations in the European Union for ALN-AT3, an RNAi Therapeutic

2014-08-11 Alnylam Pharmaceuticals, Inc. (ALNY), a leading RNAi therapeutics company, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has granted Orphan Drug Designations for ALN-AT3 as an orphan medicinal product for the treatment of hemophilia A and hemophilia B.

http://www.chemcd.com/news/2188.html

FDA Grants Orphan Drug Designation for OncoSynergy's Investigational Monoclonal Antibody OS2966

2014-08-13 OncoSynergy announced today that the FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.

http://www.chemcd.com/news/2355.html